Literature

Search Literature

You can search and request for digital copy(ies) of literature listed below. Your request will be processed within 5-10 business days. (You need to log in to request literature copies.) To read the abstracts, click on the DOI Link button.

Keyword

Filter by Protein Type

Filter by Contents

Filter by Products

You need to log in to request literature copies.

Select the literature you wish to request a copy of. To read the abstracts, click on teh DOI Link button.

36 Results Found

  1. 10
  2. 20
  3. 30
  4. All
  1. Validation and implementation of Planova™ BioEX virus filters in the manufacture of a new liquid intravenous immunoglobulin in China"

    Author
    Ma, S., et al.
    Organization
    Shandong Taibang Biological Products Co., Ltd. and Asahi Kasei Medical Co., Ltd.
    Publisher
    Biologicals 52 (2018) 37-43
    Year
    2018
    Access
    Abstract Only
  2. Characterizing the Impact of Pressure on Virus Filtration Processes and Establishing Design Spaces to Ensure Effective Parvovirus Removal

    Author
    Strauss, D., et al
    Organization
    Asahi Kasei Bioprocess America
    Publisher
    Biotechnology Process e-pub
    Year
    2017
    Access
    Open
  3. Effect of Hydrodynamic Forces on Virus Removal Capability of Planova™ Filters

    Author
    Yamamoto, A. et al.
    Organization
    Asahi Kasei Corporation
    Publisher
    AIChE Journal Vol.60, No.6 2286-2297
    Year
    2014
    Access
    Abstract Only
  4. Improved removal of viruslike particles from purified monoclonal antibody IgM preparation via virus filtration

    Author
    Maerz, H., et al.
    Organization
    University of Leipzig, Humboldt-University/Charite, Dr. Fooke Laboratorien GmbH, and Asahi Chemical Industries
    Publisher
    Nature Biotechnology 14: 651-652
    Year
    1996
    Access
    No Abstract
  5. Development, upscaling and validation of the purification process for human-cl rhFVIII (Nuwiq), a new generation recombinant factor VIII produced in a human cell-line

    Author
    Winge, S., et al.
    Organization
    Octapharma AB
    Publisher
    Protein Expression and Purification 115 (2015) 165–175
    Year
    2015
    Access
    Open
  6. Pathogen safety of intravenous Rh immunoglobulin liquid and other immune globulin products: Enhanced nanofiltration and manufacturing process overview

    Author
    Soluk, L., et al
    Organization
    Cangene Corporation and Baxter Healthcare Corporation
    Publisher
    American Journal of Therapeutics 15: 435-443
    Year
    2008
    Access
    Abstract Only
  7. Capacity of the manufacturing process of Flebogamma© DIF, a new human high purity intravenous immunoglobulin, to remove a TSE model-agent

    Author
    Diez, J. M., et al.
    Organization
    Instituto Grifols S. A.
    Publisher
    Biologicals 38: 670-674
    Year
    2010
    Access
    Abstract Only
  8. Virus removal from Factor IX by filtration: Validation of the integritytest and effect of manufacturing process conditions

    Author
    Roberts, P. L., et al.
    Organization
    Bio Products Laboratory
    Publisher
    Biologicals 38: 303-31010
    Year
    2010
    Access
    Abstract Only
  9. Viral safety of C1-inhibitor NF

    Author
    Terpstra, F. G., et al.
    Organization
    Sanquin Research and Landsteiner Laboratory of the Academic Medical Center of the University of Amsterdam and Sanquin Plasma Products
    Publisher
    Biologicals 35: 173-181
    Year
    2007
    Access
    Abstract Only
  10. Comparison of nanofiltration efficacy in reducing infectivity of centrifuged versus ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" albumin solutions

    Author
    Cardone, F., et al.
    Organization
    Istituto Superiore di Sanità, CEA/DSV/iMETI/SEPIA and LFB
    Publisher
    Transfusion 52: 953–962
    Year
    2012
    Access
    Abstract Only